TRADESHOWS

January 5, 2024

Barentz Announces a New Distribution Agreement for Ashland Vialose™ trehalose dihydrate parenteral excipient in the United States.

Barentz, a leading global life science and specialty performance ingredients distributor, has signed a distribution agreement with Ashland Inc., a global additives and specialty ingredients company, that covers its Vialose™ trehalose dihydrate functional ingredient in the United States, effective January 1, 2024.

Read More

November 1, 2023

Barentz Wins the Capitalizer Award - 2023 Modern Accounting Awards from Blackline

Barentz, a leading global distributor of life science and specialty performance ingredients throughout North America, is honored to accept the Capitalizer Award from Blackline’s 2023 Modern Accounting Awards for revolutionizing traditional accounting methods to adopt modern accounting practices.

Read More

June 20, 2023

Barentz Announces Grand Opening of State-of-the-Art Pharmaceutical Development Center.

Barentz, a global leading distributor of life science ingredients, is thrilled to announce the grand opening of its new, cutting-edge pharmaceutical development center. This state-of-the-art facility represents a significant milestone in our commitment to innovation and will serve as a collaboration hub for pharmaceutical and nutraceutical manufacturers in North America.

Read More

March 22, 2023

Barentz Expands Market Acceleration Team

Barentz, a leading global distributor of life science ingredients, is excited to welcome Bryan Daniels, as the new Market Acceleration Group Director. Daniels brings to Barentz more than two decades of progressive sales and leadership experience gained by building talented, performance-driven teams and initiating strategic plans to promote sales growth. He is a highly motivated, results-driven business professional with extensive experience maximizing revenue and market share, leading initiatives from conception to execution.

Read More

February 13, 2023

Barentz announces North American leadership transition

Barentz announces a planned leadership transition in its North America business. Mike McKenna who previously served as President & COO North America, will become CEO North America. Terry Hill, former CEO, will join the company's Supervisory Board. These appointments are effective March 1, 2023.

Read More

February 8, 2023

MEGGLE Appoints Barentz as its exclusive distributor of pharmaceutical-grade lactose for the United States

Barentz, a leading distributor of life science ingredients, is pleased to be appointed as the exclusive US distributor for MEGGLE GmbH & Co. – Business Unit Excipients, a world-leading manufacturer of pharmaceutical grades of lactose and co-processed excipients.

Read More

Page of 5